| Literature DB >> 32501257 |
Diana Canetti1, Niccolò Riccardi2, Mariano Martini3, Simone Villa4, Antonio Di Biagio5, Luigi Codecasa6, Antonella Castagna7, Ilaria Barberis8, Valentina Gazzaniga9, Giorgio Besozzi4.
Abstract
Tuberculosis is an ancient infectious disease caused by the bacillus Mycobacterium tuberculosis that is still nowadays afflicting humans all over the world. It causes ill-health for 10 million people each year. Tuberculosis (TB) has been the leading cause of death from a single infectious agent, ranking above HIV/AIDS. In recent years, infection with HIV represents a major risk factor predisposing for infection and TB is the most common cause of AIDS-related death. Despite the treatment of HIV-associated TB has essentially retraced that recommended in HIV-negative cases, it has disclosed some additional challenges over the years. The association of delayed and missed diagnoses, logistic accidents and some well-known complications of HIV and TB treatment co-administration has contributed to 300,000 people living with HIV died from a preventable and curable disease like TB in 2017. The evaluation of new diagnostic and therapeutic approaches with the struggle to erase stigma are essential to successfully manage HIV-TB coinfection.Entities:
Year: 2020 PMID: 32501257 DOI: 10.1016/j.tube.2020.101921
Source DB: PubMed Journal: Tuberculosis (Edinb) ISSN: 1472-9792 Impact factor: 3.131